| (Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) | C142H240N44O38 | 3171.74 | H-His-Ser-Asp-Ala-Val-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Lys-Arg-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-NH2 | |
| Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27), PG 97-269 | C150H246N44O38 | 3273.88 | 202463-00-1 | Ac-His-D-Phe-Asp-Ala-Val-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Lys-Arg-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-NH2 |
| AQEE-30 (human) | C157H252N48O56 | 3708.02 | 160046-70-8 | H-Ala-Gln-Glu-Glu-Ala-Glu-Ala-Glu-Glu-Arg-Arg-Leu-Gln-Glu-Gln-Glu-Glu-Leu-Glu-Asn-Tyr-Ile-Glu-His-Val-Leu-Leu-Arg-Arg-Pro-OH |
| AQEE-30 (mouse, rat) | C156H245N47O56 | 3674.94 | 323185-80-4 | H-Ala-Gln-Glu-Glu-Ala-Asp-Ala-Glu-Glu-Arg-Arg-Leu-Gln-Glu-Gln-Glu-Glu-Leu-Glu-Asn-Tyr-Ile-Glu-His-Val-Leu-Leu-His-Arg-Pro-OH |
| LQEQ-19 (human) | C106H170N30O34 | 2408.7 | H-Leu-Gln-Glu-Gln-Glu-Glu-Leu-Glu-Asn-Tyr-Ile-Glu-His-Val-Leu-Leu-Arg-Arg-Pro-OH | |
| LQEQ-19 (mouse, rat) | C106H165N29O34 | 2389.65 | 322644-72-4 | H-Leu-Gln-Glu-Gln-Glu-Glu-Leu-Glu-Asn-Tyr-Ile-Glu-His-Val-Leu-Leu-His-Arg-Pro-OH |
| Gly-Neuroendocrine Regulatory Peptide-3 (human, mouse, rat), Gly-NERP-3 | C146H234N46O52 | 3465.74 | H-Gly-Gln-Gln-Glu-Thr-Ala-Ala-Ala-Glu-Thr-Glu-Thr-Arg-Thr-His-Thr-Leu-Thr-Arg-Val-Asn-Leu-Glu-Ser-Pro-Gly-Pro-Glu-Arg-Val-Trp-OH | |
| Neuroendocrine Regulatory Peptide-4 (human, mouse, rat), NERP-4 | C87H135N25O24 | 1915.18 | 922704-18-5 | H-Asn-Ala-Pro-Pro-Glu-Pro-Val-Pro-Pro-Pro-Arg-Ala-Ala-Pro-Ala-Pro-Thr-His-Val-OH |
| Neuroendocrine Regulatory Peptide-1 (human), NERP-1 (human) | C113H192N36O39 | 2678.99 | 954420-50-9 | H-Arg-Pro-Glu-Ser-Ala-Leu-Leu-Gly-Gly-Ser-Glu-Ala-Gly-Glu-Arg-Leu-Leu-Gln-Gln-Gly-Leu-Ala-Gln-Val-Glu-Ala-NH2 |
| Neuroendocrine Regulatory Peptide-1 (rat), NERP-1 (rat) | C110H180N32O38 | 2558.83 | 954420-51-0 | H-Leu-Glu-Gly-Ser-Phe-Leu-Gly-Gly-Ser-Glu-Ala-Gly-Glu-Arg-Leu-Leu-Gln-Gln-Gly-Leu-Ala-Gln-Val-Glu-Ala-NH2 |
